Gennova Biopharma submits final vaccine trial data to regulator

​​ Pune-based Gennova is developing the country's first indigenously developed mRNA vaccine for Covid-19. The subject expert committee under the drug regulator will take up its application in its next meeting. "The date of the meeting is yet to be decided," one of the people said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/1oEPaYt
via IFTTT